Adela, Inc.

Adela, Inc. is a biotechnology company focused on transforming cancer care through blood tests. Their proprietary genome-wide methylome enrichment platform analyzes cell-free DNA to detect and classify underlying disease, enabling applications across the cancer continuum, from early detection and diagnosis to minimal residual disease monitoring and treatment management. This platform utilizes a high-affinity enrichment process to isolate the highly informative methylated regions of the genome, allowing for a more efficient and comprehensive analysis compared to other methods.

Adela is committed to developing innovative and accessible blood tests that improve patient outcomes. Their technology is tissue-agnostic, eliminating the need for invasive tumor biopsies. They are currently developing a tissue-agnostic MRD monitoring test that is expected to be commercially available in 2025, with a multi-cancer early detection product in development. Adela's approach has the potential to significantly impact the way cancer is detected and managed, ultimately leading to earlier diagnoses and more effective treatments.

Adela, Inc. is a healthcare technology company focused on transforming cancer care through innovative and accessible blood tests. Their mission is to harness the power of biology to detect cancer and other high-morbidity, high-mortality conditions earlier, leading to improved treatment outcomes and enhanced patient well-being. Their technology aims to revolutionize cancer diagnosis and management through blood-based tests for both early detection and minimal residual disease (MRD) monitoring.

Adela, Inc. promotes a culture that values teamwork, resilience, integrity, flexibility, and curiosity. They prioritize the success of the team over individual achievement, encouraging adaptability in the face of uncertainty and fostering an environment where ethical principles are paramount. They believe in giving employees autonomy and trust, while maintaining a commitment to each other and the company's goals. Finally, they embrace an open-minded approach to understanding and learning.